Stratafix Suture for Preventing Incisional Hernia
(STRATA-G Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that using slowly absorbable monofilament sutures, like those in Stratafix, can reduce the occurrence of incisional hernias after surgeries. Additionally, polydioxanone sutures, a component of Stratafix, are known for their strength and minimal tissue reaction, making them reliable for surgical use.
12345Research shows that polydioxanone, a type of absorbable suture used in Stratafix, is safe for closing abdominal wounds, with no cases of wound reopening or internal organs protruding through the wound. Incisional hernias occurred in a small percentage of cases, but overall, the suture material is considered safe.
23467The Stratafix Suture is unique because it uses a barbed design that doesn't require knots, which can provide stronger and more secure closure in high-tension areas like fascia (a layer of tissue beneath the skin). This design may help reduce the risk of incisional hernias by providing a more reliable closure compared to traditional smooth sutures.
34789Eligibility Criteria
This trial is for adults over 18 who are undergoing liver, pancreas, biliary or gastrointestinal surgery, or other major oncological surgeries at West Michigan Cancer Center. They must be able to understand the study and agree to participate. People with hemodynamic instability after surgery, a history of VIH (presumably HIV), or mental conditions affecting study comprehension cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo gastrointestinal and abdominal surgery using either Stratafix Symmetric™ sutures or standard laparotomy closure sutures
Follow-up
Participants are monitored for safety, development of ventral incisional hernia, post-operative pain, and quality of life
Participant Groups
Standard of care suture is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- General soft tissue approximation and/or ligation
- Abdominal wound closure
- Hernia repair
- Sternal closure
- General soft tissue approximation and/or ligation
- Abdominal wound closure
- Hernia repair
- Sternal closure
- Ophthalmic procedures
- Cardiovascular procedures
- Neurological procedures
- Orthopedic procedures
- Dental procedures
- General soft tissue approximation and/or ligation
- Abdominal wound closure
- Hernia repair
- Sternal closure
- General soft tissue approximation and/or ligation
- Abdominal wound closure
- Hernia repair
- Sternal closure
- General soft tissue approximation and/or ligation
- Abdominal wound closure
- Hernia repair
- Sternal closure
- General soft tissue approximation and/or ligation
- Abdominal wound closure
- Hernia repair
- Sternal closure